Benkowitz Michael

President And COO

1 company

Average

Trades Analyzed

12M Win Rate

8.7%

Avg 3M Return

+1.1%

Avg 12M Return

-28.6%

Benkowitz Michael is a President And COO at United Therapeutics Corporation. Recent SEC Form 4 filings include 0 buys and 100 sells.

Holdings by Company

UTHRFeb 23, 2026

Current Shares0

Value-

Net Activity-547,194

Bought: 0Sold: 547.2K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 23, 2026	UTHR United Therapeutics Corporation	President And COO	Sale+OE	14,440	$472.13	$6,817,499.44	-100%	+19.9%	-
Jan 26, 2026	UTHR United Therapeutics Corp	President And COO	Sale+OE	30,375	$470.03	$14,277,113.90	-36.4%	-	-
Jan 20, 2026	UTHR United Therapeutics Corp	President And COO	Sale+OE	14,625	$464.66	$6,795,626.74	-12.9%	-	-
Jan 12, 2026	UTHR United Therapeutics Corp	President And COO	Sale+OE	22,500	$479.51	$10,788,876.00	-100%	+18.5%	-
Jan 5, 2026	UTHR United Therapeutics Corp	President And COO	Sale+OE	18,123	$487.95	$8,843,160.32	-15.8%	+14.3%	-
Jan 5, 2026	UTHR United Therapeutics Corp	President And COO	Sale+OE	5,728	$486.77	$2,788,245.12	-11.6%	+14.3%	-
Dec 29, 2025	UTHR United Therapeutics Corp	President And COO	Sale+OE	22,500	$502.79	$11,312,709.75	-100%	+17.0%	-
Dec 22, 2025	UTHR United Therapeutics Corp	President And COO	Sale+OE	22,500	$514.35	$11,572,962.84	-32.7%	+1.4%	-
Dec 15, 2025	UTHR United Therapeutics Corp	President And COO	Sale+OE	22,500	$496.30	$11,166,721.88	-16.6%	+6.8%	-
Dec 8, 2025	UTHR United Therapeutics Corp	President And COO	Sale+OE	22,500	$478.58	$10,768,000.50	-100%	+10.4%	-